Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study
L. G. Estévez, P. Sánchez-Rovira, M. Dómine, A. León, I. Calvo, A. Jaén, V. Casado, G. Rubio, M. Díaz, C. Miró, F. Lobo, E. Carrasco, M. Casillas, B. San AntonioVolume:
9
Language:
english
Pages:
6
DOI:
10.1007/s12094-007-0059-7
Date:
May, 2007
File:
PDF, 80 KB
english, 2007